Baxter International Inc. is set to report its fourth-quarter results, with analysts expecting adjusted earnings of $0.54 per share and revenue of $2.84 billion. This announcement will be a key indicator of whether the medical device maker’s turnaround efforts are succeeding after facing years of operational struggles and unprofitability. Investors will focus on margin stabilization, revenue consistency, and the impact of balance sheet improvements like senior note repurchases and dividend reduction.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Baxter earnings ahead: Can medical device maker reverse losses? By Investing.com
Baxter International Inc. is set to report its fourth-quarter results, with analysts expecting adjusted earnings of $0.54 per share and revenue of $2.84 billion. This announcement will be a key indicator of whether the medical device maker’s turnaround efforts are succeeding after facing years of operational struggles and unprofitability. Investors will focus on margin stabilization, revenue consistency, and the impact of balance sheet improvements like senior note repurchases and dividend reduction.